Abstract
Mary Moran and colleagues discuss the best strategies for African regulators to be supported in their efforts to evaluate and approve drugs for their own populations.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Africa
-
Developing Countries*
-
Drug Approval / legislation & jurisprudence
-
Drug Approval / organization & administration*
-
Government Regulation
-
Humans
-
Neglected Diseases / drug therapy*
-
Poverty
-
Registries*